Texas man fourth in U.S. to die from rare brain disease: CDC

AUSTIN Texas Thu Jun 5, 2014 1:45pm EDT

Related Topics

AUSTIN Texas (Reuters) - A Texas man has died of the fatal brain illness variant Creutzfeldt-Jakob Disease, the fourth person to die of the disease in the United States, according to the Centers for Disease Control.

CJD is a rare, degenerative, fatal brain disorder in humans, believed to be caused by consumption of products from cows with bovine spongiform encephalopathy (BSE), or "mad cow" disease.

"The history of this fourth patient, including extensive travel to Europe and the Middle East, supports the likelihood that infection occurred outside the United States," the CDC said in a statement this week.

In each of the three previous cases, infection likely occurred outside the United States, it said. The Texas patient was not identified.

(Reporting by Jon Herskovitz, editing by G Crosse)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (9)
mothman32 wrote:
There is no way to know when or where infection happened!

Jun 05, 2014 4:33pm EDT  --  Report as abuse
CmdrBuzz wrote:
My brother-in-law died of CJD a few years ago. He was also in Texas.

Jun 05, 2014 5:28pm EDT  --  Report as abuse
Dtayls wrote:
“…supports the likelihood that infection occurred outside the United States,” Yeah, sure. With NO random testing for mad cow disease ALLOWED in meat processing plants or stockyards in the United States, we should believe the CDC? Random testing should be mandated, not forbidden.

Jun 05, 2014 5:29pm EDT  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.